NCBP2 |
NCBP2, CBP20, PIG55: Nuclear cap-binding protein subunit 2 |
KPNB1 |
KPNB1, NTF97: Importin subunit beta-1 |
47.4 |
Evidence |
O
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
47.370 |
Evidence |
|
FGR |
FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR |
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
47.370 |
Evidence |
|
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
EPHB1 |
EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor |
47.370 |
Evidence |
|
PDGFRA |
PDGFRA: Alpha-type platelet-derived growth factor receptor precursor |
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
47.370 |
Evidence |
|
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
BTK |
BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK |
47.370 |
Evidence |
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
47.370 |
Evidence |
|
EPHB3 |
EPHB3, ETK2, HEK2, TYRO6: Ephrin type-B receptor 3 precursor |
LYN |
LYN: Tyrosine-protein kinase Lyn |
47.370 |
Evidence |
|
ERBB2 |
ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor |
SYK |
SYK: Tyrosine-protein kinase SYK |
47.370 |
Evidence |
|
EPHB2 |
EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
47.370 |
Evidence |
|
INSR |
INSR: Insulin receptor precursor |
CSK |
CSK: Tyrosine-protein kinase CSK |
47.370 |
Evidence |
|
PLK4 |
PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
47.320 |
Evidence |
|
PLK4 |
PLK4, SAK, STK18: Serine/threonine-protein kinase PLK4 |
MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
47.320 |
Evidence |
|
SMAD3 |
SMAD3, MADH3: Mothers against decapentaplegic homolog 3 |
MTF1 |
MTF1: Metal regulatory transcription factor 1 |
47.290 |
Evidence |
|
PRKCI |
PRKCI, DXS1179E: Protein kinase C iota type |
WWC2 |
WW and C2 domain containing 2 |
47.290 |
Evidence |
|
MET |
MET: Hepatocyte growth factor receptor precursor |
STAT5A |
STAT5A, STAT5: Signal transducer and activator of transcription 5A |
47.270 |
Evidence |
|
CSK |
CSK: Tyrosine-protein kinase CSK |
TEK |
TEK, TIE2: Angiopoietin-1 receptor precursor |
47.270 |
Evidence |
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
IRF3 |
IRF3: Interferon regulatory factor 3 |
47.110 |
Evidence |
|
F10 |
F10: Coagulation factor X precursor |
MGMT |
MGMT: Methylated-DNA--protein-cysteine methyltransferase |
47.110 |
Evidence |
|
TP53 |
TP53, P53: Cellular tumor antigen p53 |
MCM3 |
MCM3: DNA replication licensing factor MCM3 |
46.930 |
Evidence |
|
SFRS10 |
SFRS10, TRA2B: Splicing factor, arginine/serine-rich 10 |
PIP5K3 |
PIP5K3, KIAA0981, PIKFYVE: FYVE finger-containing phosphoinositide kinase |
46.930 |
Evidence |
|
SYK |
SYK: Tyrosine-protein kinase SYK |
CD2AP |
CD2AP: CD2-associated protein |
46.900 |
Evidence |
|
SERPING1 |
SERPING1, C1IN, C1NH: Plasma protease C1 inhibitor precursor |
PCOLCE |
PCOLCE, PCPE1: Procollagen C-endopeptidase enhancer 1 precursor |
46.900 |
Evidence |
|
DOK1 |
DOK1: Docking protein 1 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
46.900 |
Evidence |
|
TNFRSF1B |
TNFRSF1B, TNFBR, TNFR2: Tumor necrosis factor receptor superfamily member 1B pre |
TNFRSF1A |
TNFRSF1A, TNFAR, TNFR1: Tumor necrosis factor receptor superfamily member 1A pre |
46.900 |
Evidence |
|